TI
TSHA icon

Trexquant Investment’s Taysha Gene Therapies TSHA Stock Holding History

Trexquant Investment’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Buy
+379,577
New +$2.25M 0.02% 1079
2022
Q3 		– Sell
-19,548
Closed -$73K – 1845
2022
Q2 		$73K Sell
19,548
-51,935
-73% -$206K ﹤0.01% 1450
2022
Q1 		$466K Buy
71,483
+41,852
+141% +$313K 0.02% 797
2021
Q4 		$345K Buy
+29,631
New +$447K 0.02% 845

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Trexquant Investment's TSHA Position: Q2 2026 in Review

Trexquant Investment opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 379,577 shares worth $2.58M. The stake represents 0.02% of the portfolio and ranks #1079 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in TSHA as recently as Q2 2022.

Trexquant Investment first reported a position in TSHA in Q4 2021 and has held it in 4 quarters since. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Trexquant Investment held 379,577 shares of Taysha Gene Therapies worth $2.58M as of Q2 2026.
  • Taysha Gene Therapies was a new Trexquant Investment position in Q2 2026.
  • Taysha Gene Therapies made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #1079 holding.
  • Trexquant Investment first reported a position in Taysha Gene Therapies in Q4 2021 and has held it in 4 quarters since.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.